Joseph M. Coney, MD, FACS, explores strategies to address treatment obstacles among vulnerable patients and examines the effects of step therapy and prior authorization within a complex health care ...

Every day Melissa Fulton, RN, MSN, FNP, APRN-C, shows up to work, she's ready for another fight. An advanced practice nurse who specializes in multiple sclerosis care, Fulton says she typically spends ...

Kim Albin has lost count of the number of times she’s had to battle health insurance companies over medications. Albin, who has been living with multiple sclerosis for nearly 30 years, said health ...

As science makes once-unthinkable treatments available, patients are increasingly facing a harsh reality: Insurance companies are forcing them to try older, less expensive therapies for months before ...

Panelists discuss how step-therapy for immunoglobulin A (IgA) nephropathy is evolving toward a more personalized approach, starting with optimized supportive care before progressing to targeted ...

The Massachusetts House passed a bill which aims to curb the use of step therapy by health insurers. Drugs that are designated with a “step therapy” condition of reimbursement are only paid for by ...

Even when doctors prescribe a medication, some insurance companies require you to try lower-cost drugs first, which could delay your ability to get the treatment you need. Samantha Rynearson was 21 ...

Please provide your email address to receive an email when new articles are posted on . Despite a mounting number of state-level laws enacted to protect vulnerable patients against step therapy ...